Christina H. Ruhlmann, Associate Professor at OUH Odense University Hospital, shared a post on LinkedIn:
”Calling my Immune-Oncology Network in Europe.
A project under the auspices of the ESMO Faculty of Supportive and Palliative Care and the Practicing Oncology Working Group aims to assess the current management of immune-related adverse events (irAEs). The results will inform us about the differential needs for improving management strategies impacting a continuously growing number of cancer patients receiving immune checkpoint inhibitors.
On behalf of the incredible European IO-tox Group, I invite you to take this short survey – thank you!
Use the following link if the QR code fails.”
More posts featuring Christina H. Ruhlmann.